Clinical Trial Update: Efficacy of Granulocyte Colony Stimulating Factor (GCSF) In Patients With Dystrophic Epidermolysis Bullosa [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated the efficacy of granulocyte colony-stimulating factor (G-CSF) in patients with dystrophic epidermolysis bullosa; results were posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dystrophic Epidermolysis Bullosa

Drugs mentioned

• Granulocyte Colony-Stimulating Factor (G-CSF) (G-CSF)

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Dystrophic Epidermolysis Bullosa | Phase 2 | Status: COMPLETED | Results posted: 2017-04-25